Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:42 PM
Ignite Modification Date: 2025-12-25 @ 12:37 PM
NCT ID: NCT01063595
Description: Safety population: All participants who received at least 1 of the study treatments in any study period.
Frequency Threshold: 5
Time Frame: None
Study: NCT01063595
Study Brief: A Trial to Investigate the Relative Efficacy, Safety, and Tolerability of Octaplas LG Versus Octaplas SD
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Octaplas LG Participants received 1200 mL of Octaplas LG intravenously once. None None 1 60 34 60 View
Octaplas SD Participants received 1200 mL of Octaplas SD intravenously once. None None 0 60 39 60 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Anaphylactic shock SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (13.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Paraesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (13.0) View
Paraesthesia oral SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (13.0) View
Vertigo SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (13.0) View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (13.0) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (13.0) View
Urticaria SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (13.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (13.0) View
Urticaria SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA (13.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (13.0) View